VivoSim Labs, Inc. Accumulated Other Comprehensive Income
VivoSim Labs, Inc. (VIVS) had Accumulated Other Comprehensive Income of $1.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-11-08
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2024-09-30 | $1.00K 10-Q · filed 2024-11-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-11-08 |
| 2023-12-31 | $1.00K 10-Q · filed 2024-02-08 |
| 2023-09-30 | $1.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.00K 10-K · filed 2024-05-31 |
| 2022-12-31 | $3.00K 10-Q · filed 2023-02-09 |
| 2022-03-31 | $0.00 10-K · filed 2023-07-14 |
| 2018-03-31 | $0.00 10-K · filed 2018-05-31 |
| 2017-12-31 | -$13.00K 10-Q · filed 2018-02-08 |
| 2017-09-30 | -$11.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$11.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$11.00K 10-K · filed 2018-05-31 |
| 2016-03-31 | $0.00 10-K · filed 2017-06-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |